SAT0152 A Randomised, Double-Blind, Phase III Study Comparing SB2, An Infliximab Biosimilar, To the Infliximab Reference Product (Remicade®) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
Choe, J.-Y., Prodanovic, N., Niebrzydowski, J., Staykov, I., Dokoupilova, E., Baranauskaite, A., Yatsyshyn, R., Mekic, M., Porawska, W., Ciferska, H., Jedrychowicz-Rosiak, K., Zielinska, A., Bang, J.YVolume:
74
Langue:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2015-eular.1583
Date:
June, 2015
Fichier:
PDF, 135 KB
english, 2015
File converter
Plus de résultats de recherche
More benefits 
